Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rumley

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Bone & Joint Research|April 18, 2014
Systemic effects of polymethylmethycrylate in total knee replacement: A prospective case-control studyK Cheng, D Giebaly, A Campbell, et al.
Clinical Chemistry|May 1, 1993
Increased fetal hemoglobin in insulin-treated diabetes mellitus contributes to the imprecision of glycohemoglobin measurementsE S Kilpatrick, M Small, A Rumley, et al.
British Journal of Haematology|March 2, 1999
Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular diseaseM Woodward, A Rumley, H Tunstall-Pedoe, et al.
European Heart Journal|March 21, 1998
Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. The Scottish Heart Health StudyM Woodward, G D Lowe, A Rumley, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2007
A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart diseaseM Woodward, A Rumley, P Welsh, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 1, 1997
Acute exercise and markers of endothelial injury in peripheral arterial diseaseK R Woodburn, A Rumley, A Murtagh, et al.
Thrombosis and Haemostasis|July 15, 1999
Activated protein C resistance and the FV:R506Q mutation in a random population sample--associations with cardiovascular risk factors and coagulation variablesG D Lowe, A Rumley, M Woodward, et al.
Thrombosis and Haemostasis|January 5, 2002
Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failureA P Davie, A Rumley, G D Lowe, et al.
British Heart Journal|June 1, 1995
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatmentG Y Lip, G D Lowe, A Rumley, et al.
Thrombosis and Haemostasis|September 1, 1995
Fibrin D-dimer, haemostatic factors and peripheral arterial diseaseA J Lee, F G Fowkes, G D Lowe, et al.
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Bone & Joint Research|April 18, 2014
Systemic effects of polymethylmethycrylate in total knee replacement: A prospective case-control studyK Cheng, D Giebaly, A Campbell, et al.
Clinical Chemistry|May 1, 1993
Increased fetal hemoglobin in insulin-treated diabetes mellitus contributes to the imprecision of glycohemoglobin measurementsE S Kilpatrick, M Small, A Rumley, et al.
British Journal of Haematology|March 2, 1999
Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular diseaseM Woodward, A Rumley, H Tunstall-Pedoe, et al.
European Heart Journal|March 21, 1998
Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. The Scottish Heart Health StudyM Woodward, G D Lowe, A Rumley, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2007
A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart diseaseM Woodward, A Rumley, P Welsh, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 1, 1997
Acute exercise and markers of endothelial injury in peripheral arterial diseaseK R Woodburn, A Rumley, A Murtagh, et al.
Thrombosis and Haemostasis|July 15, 1999
Activated protein C resistance and the FV:R506Q mutation in a random population sample--associations with cardiovascular risk factors and coagulation variablesG D Lowe, A Rumley, M Woodward, et al.
Thrombosis and Haemostasis|January 5, 2002
Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failureA P Davie, A Rumley, G D Lowe, et al.
British Heart Journal|June 1, 1995
Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatmentG Y Lip, G D Lowe, A Rumley, et al.
Thrombosis and Haemostasis|September 1, 1995
Fibrin D-dimer, haemostatic factors and peripheral arterial diseaseA J Lee, F G Fowkes, G D Lowe, et al.
Pageof 12